Zhejiang Jiangbei Pharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files and 5 valid CEPs across a filed portfolio of 4 molecules. Its GMP standing is certified by EMA, US FDA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 7 July 2023 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| TAIZHOU, China | Not on file |
| TAIZHOU, China | Not on file |
| Taizhou City, China | Not on file |
| China, China | 3004986814 |
| Molecule | Regulators | Docs |
|---|---|---|
| Simvastatin | EDQM, US FDA | 4 |
| Atorvastatin | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Levetiracetam | EDQM | 1 |
| Rosuvastatin | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
| US FDA | None | 1 |
| MHRA (UK) | None | 1 |
Choose your molecules and target markets. Zhejiang Jiangbei Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free